Home  |  Contact

Cellosaurus MCF-7 RR1 (CVCL_IU96)

[Text version]

Cell line name MCF-7 RR1
Synonyms MCF-7_RR1
Accession CVCL_IU96
Resource Identification Initiative To cite this cell line use: MCF-7 RR1 (RRID:CVCL_IU96)
Comments Selected for resistance to: ChEBI; CHEBI:9168; Sirolimus (Rapamycin).
Sequence variations MTOR p.Ala2034Val (PubMed=27279227).
Homozygous for CDKN2A deletion (from parent cell line).
Heterozygous for PIK3CA p.Glu545Lys (c.1633G>A) (ClinVar=VCV000013655) (from parent cell line).
Disease Invasive ductal carcinoma, not otherwise specified (NCIt: C4194)
Derived from metastatic site: Pleural effusion.
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_0031 (MCF-7)
Sex of cell Female
Age at sampling 69Y
Category Cancer cell line
Publications

PubMed=27279227; DOI=10.1038/nature17963
Rodrik-Outmezguine V.S., Okaniwa M., Yao Z., Novotny C.J., McWhirter C., Banaji A., Won H., Wong W., Berger M., de Stanchina E., Barratt D.G., Cosulich S., Klinowska T., Rosen N., Shokat K.M.
Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor.
Nature 534:272-276(2016)

Cross-references
Other Wikidata; Q54904323
Polymorphism and mutation databases Cosmic; 2553503
Entry history
Entry creation03-Mar-2017
Last entry update02-Jul-2020
Version number7